In this JAMA Oncology Narrative Review, the authors attempt to discover whether cardiovascular risks may be associated with the multimodal approach, including systemic therapies and breast radiotherapy (RT), in treating breast cancer patients. Although recent advancements in breast cancer treatment have led to a decrease in mortality rates, the prevalence of survivors with a potentially […]
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are cornerstones of cardiovascular disease therapy. In this article (registration required) from the Cleveland Clinic Journal of Medicine, the author provides insight and commentary on whether ACE inhibitors are better than ARBs. The conclusion is there is more to the story and the evidence than […]
According to the results of a new clinical trial published in The New England Journal of Medicine (NEJM), a simple treatment that combines four heart medicines in one pill—a “polypill”—was able to cut the risk of heart attack, stroke, and other cardiovascular events by 21% in people at risk of heart disease, and by 31% […]
According to the American Academy of Pediatrics (AAP) recommendations in “COVID-19 Interim Guidance: Return to Sports”, a positive cardiac screen or other concerning findings from a recovered COVID-19 youth patient should prompt an electrocardiogram (EKG) and potential referral to a pediatric cardiologist. The updated guidance has a focus on cardiac evaluation.
In this podcast, Dr. Jennifer Caudle speaks with Drs. Kathryn Ruddy and Joerg Herrmann from the cardio-oncology clinic at the Mayo Clinic to talk about the field that’s devoted to improving cardiovascular health both during and after cancer therapy.